Author: Tristan Fairleigh

Dec 30, 2025

Market Competition: How Multiple Generic Drug Competitors Really Affect Prices

Multiple generic drug competitors don't always mean lower prices. Market structure, regulatory rules, and strategic behavior among companies often limit real competition - even when dozens of generics are approved.

Dec 29, 2025

How to Access FDA Adverse Event Databases for Safety Monitoring

Learn how to access and use the FDA's FAERS database for spotting drug safety signals. Free tools, real examples, and what the data can - and can't - tell you about side effects.

Dec 28, 2025

How to Communicate with Multiple Healthcare Providers About Your Medications

Learn how to prevent dangerous medication errors by communicating clearly with multiple healthcare providers. Get practical steps to organize your meds, work with your pharmacist, and ensure all your doctors are on the same page.

Dec 27, 2025

Combination Drug Substitution: Legal and Practical Challenges in Modern Pharmacy

Combination drug substitution poses legal and safety challenges as pharmacy laws struggle to keep up with multi-drug treatments. Patients and pharmacists face confusion over what can be swapped-and when it's dangerous.

Dec 26, 2025

Cannabis and CNS Depressants: What You Need to Know About Additive Sedation Risks

Combining cannabis with CNS depressants like benzodiazepines or opioids can cause dangerous additive sedation, slowed breathing, and overdose. Learn the risks, real cases, and how to stay safe.

Dec 25, 2025

Inflammatory Bowel Disease: Crohn’s Disease vs. Ulcerative Colitis

Crohn’s disease and ulcerative colitis are two distinct forms of inflammatory bowel disease with different causes, symptoms, and treatments. Learn how they differ in location, depth of inflammation, complications, and management.

Dec 24, 2025

Pharmacokinetic Studies: The Real Standard for Proving Generic Drug Equivalence

Pharmacokinetic studies are the main way regulators prove generic drugs work like brand-name versions. But they're not perfect. For some drugs, blood tests don't tell the whole story-and patient safety depends on knowing when they fall short.

Dec 23, 2025

Quality by Design in Generic Drug Development: Modern Science-Based Approaches

Quality by Design (QbD) is now mandatory for generic drug development, transforming how manufacturers prove bioequivalence. Learn how science-based approaches like design space, CQAs, and PAT reduce costs, speed approvals, and improve product consistency.